Current status of alloHSCT in BP-MPNs
Guillermo Ortí, MD, PhD, Vall d'Hebron Institute of Oncology, Barcelona, Spain, talks on the current status of allogeneic hematopoietic stem cell transplantation (alloHSCT) in blast phase myeloproliferative neoplasms (BP-MPNs). Dr Ortí explains that patients with BP-MPNs are usually older, and are often not transplant-eligible. Nevertheless, a minority of patients who are transplant-eligible are able to achieve long-term overall survival (OS) and progression-free survival (PFS). In the future, it will be important to determine which patients derive the most benefit from alloHSCT. This interview took place at the 48th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2022, which was held virtually.
Watch video Current status of alloHSCT in BP-MPNs online without registration, duration hours minute second in high quality. This video was added by user VJHemOnc – Video Journal of Hematology & HemOnc 07 April 2022, don't forget to share it with your friends and acquaintances, it has been viewed on our site 27 once and liked it 0 people.